Dong Ying, Harrington Brittney S, Adams Mark N, Wortmann Andreas, Stephenson Sally-Anne, Lisle Jessica, Herington Adrian, Hooper John D, Clements Judith A
Biol Chem. 2014 Sep;395(9):977-90. doi: 10.1515/hsz-2014-0147.
The 15 members of the kallikrein-related serine peptidase (KLK) family have diverse tissue-specific expression profiles and roles in a range of cellular processes, including proliferation, migration, invasion, differentiation, inflammation and angiogenesis that are required in both normal physiology as well as pathological conditions. These roles require cleavage of a range of substrates, including extracellular matrix proteins, growth factors, cytokines as well as other proteinases. In addition, it has been clear since the earliest days of KLK research that cleavage of cell surface substrates is also essential in a range of KLK-mediated cellular processes where these peptidases are essentially acting as agonists and antagonists. In this review we focus on these KLK-regulated cell surface receptor systems including bradykinin receptors, proteinase-activated receptors, as well as the plasminogen activator, ephrins and their receptors, and hepatocyte growth factor/Met receptor systems and other plasma membrane proteins. From this analysis it is clear that in many physiological and pathological settings KLKs have the potential to regulate multiple receptor systems simultaneously; an important issue when these peptidases and substrates are targeted in disease.
激肽释放酶相关丝氨酸蛋白酶(KLK)家族的15个成员具有多样的组织特异性表达谱,并在一系列细胞过程中发挥作用,包括增殖、迁移、侵袭、分化、炎症和血管生成,这些过程在正常生理以及病理状况下均是必需的。这些作用需要切割一系列底物,包括细胞外基质蛋白、生长因子、细胞因子以及其他蛋白酶。此外,自KLK研究最初阶段起就已明确,在一系列KLK介导的细胞过程中,细胞表面底物的切割也至关重要,在这些过程中这些肽酶主要充当激动剂和拮抗剂。在本综述中,我们聚焦于这些受KLK调节的细胞表面受体系统,包括缓激肽受体、蛋白酶激活受体,以及纤溶酶原激活剂、 Ephrin及其受体,还有肝细胞生长因子/Met受体系统和其他质膜蛋白。通过这一分析可知,在许多生理和病理情况下,KLK有可能同时调节多个受体系统;当这些肽酶和底物成为疾病治疗靶点时,这是一个重要问题。